Additional file 2: Figure S2. of Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis
| Autor: | T. Huizinga, A. Batalov, R. Stoilov, E. Lloyd, T. Wagner, D. Saurigny, B. Souberbielle, E. Esfandiari |
|---|---|
| Rok vydání: | 2017 |
| DOI: | 10.6084/m9.figshare.c.3712711_d2.v1 |
| Popis: | Flow diagram showing patient disposition. DMARDs disease-modifying antirheumatic drugs, HIV human immunodeficiency virus, IgG, immunoglobulin G (PDF 16 kb) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|